ID   MDR1_RAT                Reviewed;        1277 AA.
AC   P43245; Q63426; Q63427;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   24-JUL-2024, entry version 171.
DE   RecName: Full=ATP-dependent translocase ABCB1 {ECO:0000250|UniProtKB:P08183};
DE   AltName: Full=ATP-binding cassette sub-family B member 1;
DE   AltName: Full=Multidrug resistance protein 1;
DE            EC=7.6.2.2 {ECO:0000250|UniProtKB:P08183};
DE   AltName: Full=P-glycoprotein 1;
DE   AltName: Full=Phospholipid transporter ABCB1 {ECO:0000305};
DE            EC=7.6.2.1 {ECO:0000250|UniProtKB:P08183};
DE   AltName: CD_antigen=CD243;
GN   Name=Abcb1 {ECO:0000312|RGD:3318}; Synonyms=Mdr1, Mdr1b, Pgy1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1682220; DOI=10.1016/0378-1119(91)90203-n;
RA   Silverman J.A., Raunio H., Gant T.W., Thorgeirsson S.S.;
RT   "Cloning and characterization of a member of the rat multidrug resistance
RT   (mdr) gene family.";
RL   Gene 106:229-236(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1212-1277.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1348630; DOI=10.1016/0167-4781(92)90523-3;
RA   Deuchars K.L., Duthie M., Ling V.;
RT   "Identification of distinct P-glycoprotein gene sequences in rat.";
RL   Biochim. Biophys. Acta 1130:157-165(1992).
CC   -!- FUNCTION: Translocates phospholipids and drugs across the membrane.
CC       Catalyzes the flop of phospholipids from the cytoplasmic to the
CC       exoplasmic leaflet of the apical membrane. Participates mainly to the
CC       flop of phosphatidylcholine, phosphatidylethanolamine, beta-D-
CC       glucosylceramides and sphingomyelins. Energy-dependent efflux pump
CC       responsible for decreased drug accumulation in multidrug-resistant
CC       cells. {ECO:0000250|UniProtKB:P08183}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + phospholipidSide 1 = ADP + phosphate +
CC         phospholipidSide 2.; EC=7.6.2.1;
CC         Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(in) + ATP + H2O
CC         = a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:36439, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:64612, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine(out) + ATP + H2O = a
CC         1,2-diacyl-sn-glycero-3-phosphocholine(in) + ADP + H(+) + phosphate;
CC         Xref=Rhea:RHEA:38583, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57643,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine(in) + ATP +
CC         H2O = a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine(out) + ADP +
CC         H(+) + phosphate; Xref=Rhea:RHEA:38943, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:22801, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sphingomyelin(in) + ATP + H2O = a sphingomyelin(out) + ADP +
CC         H(+) + phosphate; Xref=Rhea:RHEA:38903, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P08183};
CC   -!- ACTIVITY REGULATION: Translocase activity is inhibited by verapamil and
CC       is sensitive to energy depletion. C1orf115 regulates drug efflux
CC       through modulation of ABCB1 localization and activity.
CC       {ECO:0000250|UniProtKB:P08183}.
CC   -!- SUBUNIT: Interacts with PSMB5. Finds in a complex with ABCB1, TFPI2 and
CC       PPP2R3C; leading to the dephosphorylation of ABCB1.
CC       {ECO:0000250|UniProtKB:P08183}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P08183};
CC       Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441}.
CC       Apical cell membrane {ECO:0000250|UniProtKB:P08183}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P08183}. Note=ABCB1 localization is influenced
CC       by C1orf115 expression levels (plasma membrane versus cytoplasm).
CC       {ECO:0000250|UniProtKB:P08183}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB family.
CC       Multidrug resistance exporter (TC 3.A.1.201) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M81855; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X61103; CAA43415.1; -; Genomic_DNA.
DR   EMBL; X61104; CAA43416.1; -; Genomic_DNA.
DR   PIR; JH0502; JH0502.
DR   AlphaFoldDB; P43245; -.
DR   SMR; P43245; -.
DR   ChEMBL; CHEMBL1075229; -.
DR   GlyCosmos; P43245; 2 sites, No reported glycans.
DR   GlyGen; P43245; 2 sites.
DR   iPTMnet; P43245; -.
DR   PhosphoSitePlus; P43245; -.
DR   PaxDb; 10116-ENSRNOP00000049952; -.
DR   AGR; RGD:3318; -.
DR   RGD; 3318; Abcb1.
DR   eggNOG; KOG0055; Eukaryota.
DR   InParanoid; P43245; -.
DR   PhylomeDB; P43245; -.
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-9754706; Atorvastatin ADME.
DR   Reactome; R-RNO-9757110; Prednisone ADME.
DR   PRO; PR:P43245; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0098591; C:external side of apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IDA:RGD.
DR   GO; GO:0046581; C:intercellular canaliculus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0140328; F:floppase activity; ISS:UniProtKB.
DR   GO; GO:0090554; F:phosphatidylcholine floppase activity; IBA:GO_Central.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0071217; P:cellular response to external biotic stimulus; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0099040; P:ceramide translocation; IBA:GO_Central.
DR   GO; GO:0014045; P:establishment of endothelial blood-brain barrier; IMP:RGD.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0045332; P:phospholipid translocation; IBA:GO_Central.
DR   GO; GO:0001890; P:placenta development; IEP:RGD.
DR   GO; GO:0097327; P:response to antineoplastic agent; IEP:RGD.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0033595; P:response to genistein; IEP:RGD.
DR   GO; GO:1903416; P:response to glycoside; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0010212; P:response to ionizing radiation; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010046; P:response to mycotoxin; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0061843; P:Sertoli cell barrier remodeling; IMP:RGD.
DR   CDD; cd18558; ABC_6TM_Pgp_ABCB1; 1.
DR   CDD; cd18578; ABC_6TM_Pgp_ABCB1_D2_like; 1.
DR   CDD; cd03249; ABC_MTABC3_MDL1_MDL2; 2.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039421; Type_1_exporter.
DR   PANTHER; PTHR43394:SF11; ALPHA-FACTOR-TRANSPORTING ATPASE; 1.
DR   PANTHER; PTHR43394; ATP-DEPENDENT PERMEASE MDL1, MITOCHONDRIAL; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Cytoplasm; Glycoprotein; Lipid transport;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Translocase; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1277
FT                   /note="ATP-dependent translocase ABCB1"
FT                   /id="PRO_0000093335"
FT   TOPO_DOM        1..42
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        43..65
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        66..115
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        116..136
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        137..185
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        186..207
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        208..214
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        215..235
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        236..293
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        294..315
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        316..329
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        330..351
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        352..709
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        710..730
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        731..754
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        755..775
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        776..830
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        831..853
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        854
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        855..874
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        875..934
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        935..957
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        958..973
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        974..995
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        996..1277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   DOMAIN          49..356
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          391..627
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          709..1000
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1035..1272
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          633..660
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        633..656
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         426..433
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         1070..1077
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   MOD_RES         641
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06795"
FT   MOD_RES         659
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06795"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        96
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        1227
FT                   /note="V -> I (in Ref. 2; CAA43415/CAA43416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1270
FT                   /note="V -> VSV (in Ref. 2; CAA43415)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1277 AA;  141387 MW;  8AFDDD619D2934C1 CRC64;
     MEFEEGLNGR ADKNFSKMGK KSKKEKEKKP AVGIFGMFRY ADWLDKLCMA LGTLAAIIHG
     TLLPLLMLVF GYMTDSFTPS RDPHSDRAIT NQSEINSTHT VSDTSLEEDM AMYAYYYTGI
     GAGVLIVAYI QVSLWCLAAG RQIHKIRQKF FHAIMNQEIG WFDVNDAGEL NTRLTDDVSK
     INDGIGDKLG MFFQSITTFS AGFIIGFISG WKLTLVILAV SPLIGLSSAM WAKVLTSFTN
     KELQAYAKAG AVAEEVLAAI RTVIAFGGQK KELERYNKNL EEAKRVGIKK AITANISIGI
     AYLLVYASYA LAFWYGTSLV LSNEYSIGQV LTVFFSILLG TFSIGHLAPN IEAFANARGA
     AYEIFKIIDN EPSIDSFSTK GHKPDSIMGN LEFKNVYFNY PSRSEVKILK GLNLKVKSGQ
     TVALVGNSGC GKSTTVQLLQ RLYDPIEGEV SIDGQDIRTI NVRYLREIIG VVSQEPVLFA
     TTIAENIRYG RENVTMDEIE KAVKEANAYD FIMKLPHKFD TLVGERGAQL SGGQKQRIAI
     ARALVRNPKI LLLDEATSAL DTESEAVVQA ALDKAREGRT TIVIAHRLST VRNADVIAGF
     DGGVIVEQGN HEELMKEKGI YFKLVMTQTR GNEIEPGNNA YESQSDTGAS ELTSEESKSP
     LIRRSIRRSI HRRQDQERRL SSKEDVDEDV PMVSFWQILK LNISEWPYLV VGVLCAVING
     CIQPVFAIVF SKIVGVFSRD DDHETKQRNC NLFSLLFLVM GMISFVTYFF QGFTFGKAGE
     ILTKRLRYMV FKSMLRQDIS WFDDHKNTTG SLTTRLASDA SNVKGAMGSR LAVVTQNVAN
     LGTGIILSLV LVYGWQLTLL LVVIIPLIVL GGIIEMKLLS GQALKDKKEL EISGKIATEA
     IENFRTVVSL TREQKFETMY AQSLQIPYRN ALKKAHVFGI TFAFTQAMIY FSYAACFRFG
     AYLVARELMT FENVMLVFSA VVFGAMAAGN TSSFAPDYAK AKVSASHIIG IIEKIPEIDS
     YSTEGLKPNW LEGNVKFNGV KFNYPTRPNI PVLQGLSFEV KKGQTLRLVG SSGCGKSTVV
     QLLERFYNPM AGTVFLDGKE IKQLNVQCVR ALGIVSQEPI LFDCSIAENI AYGDNSRVVS
     HEEIVRAARE ANIHQFIDSL PEKYNTRVGD KGTQLSGGQK QRIAIARALV RQPHILLLDE
     ATSALDTESE KVVQEALDKA REGRTCVVIA HRLSTIQNAD LIVVIQNGQV KEHGTHQQLL
     AQKGIYFSMV QAGAKRS
//
